|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Aeglea Biotherapeutics, Inc. (AGLE) |
|
|
$0.60 0.00 (0.00%) as of 4:30 Thu 9/7
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
61,170,000 |
| Market
Cap: |
36.74(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.1064 - $0.6766 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Aeglea BioTherapeutics is a holding company. Through its subsidiaries, Co. is a biotechnology company developing human enzyme therapeutics for people with rare metabolic diseases. Co.'s development programs include: Pegzilarginase in Arginase 1 Deficiency, which is a recombinant human Arginase 1 that enzymatically degrades the amino acid arginine and improves the stability and arginine-degrading activity of the enzyme in human plasma; and AGLE-177 in Homocystinuria, which is a PEGylated, or polyethylene glycol modified, human enzyme engineered to degrade free homocysteine and homocystine. Co.'s preclinical pipeline includes cystinuria program to reduce plasma cystine and cysteine levels.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
118,200 |
| Total Buy Value |
$0 |
$0 |
$0 |
$70,494 |
| Total People Bought |
0 |
0 |
0 |
2 |
| Total Buy Transactions |
0 |
0 |
0 |
2 |
| Total Shares Sold |
0 |
3,435,480 |
3,435,480 |
3,435,480 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
1 |
1 |
1 |
| Total Sell Transactions |
0 |
1 |
1 |
1 |
| End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Alspaugh Jonathan |
Chief Financial Officer |
• – – |
2021-08-17 |
4 |
B |
$6.50 |
$151,985 |
D/D |
23,392 |
33,172 |
2.74 |
-34% |
|
| Alspaugh Jonathan |
Chief Financial Officer |
• – – |
2021-08-16 |
4 |
B |
$6.37 |
$62,275 |
D/D |
9,780 |
9,780 |
2.74 |
-34% |
|
| Baker Julian |
Director |
– • – |
2021-02-23 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
3,410,106 |
|
-1% |
|
| Weber Steven |
VP, Controller&Princ Acctg Off |
• – – |
2021-02-02 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
17,652 |
|
-13% |
|
| Quinn Anthony |
President & CEO |
• • – |
2020-04-30 |
4 |
B |
$4.75 |
$783,750 |
D/D |
165,000 |
538,469 |
2.81 |
-9% |
|
| Quinn Anthony |
President & CEO |
• • – |
2019-10-04 |
4 |
OE |
$5.46 |
$114,689 |
D/D |
18,265 |
371,908 |
|
- |
|
| Quinn Anthony |
President & CEO |
• • – |
2019-06-14 |
4 |
B |
$6.23 |
$32,913 |
D/D |
5,282 |
353,643 |
2.81 |
- |
|
| Quinn Anthony |
President & CEO |
• • – |
2019-06-13 |
4 |
B |
$6.17 |
$88,836 |
D/D |
14,406 |
348,361 |
2.81 |
- |
|
| Quinn Anthony |
President & CEO |
• • – |
2019-06-12 |
4 |
B |
$6.11 |
$74,705 |
D/D |
12,217 |
333,955 |
2.81 |
- |
|
| Quinn Anthony |
President & CEO |
• • – |
2019-05-22 |
4 |
B |
$6.86 |
$26,128 |
D/D |
3,809 |
321,738 |
2.81 |
- |
|
| Quinn Anthony |
President & CEO |
• • – |
2019-05-21 |
4 |
B |
$6.89 |
$94,981 |
D/D |
13,794 |
317,929 |
2.81 |
- |
|
| Quinn Anthony |
President & CEO |
• • – |
2019-05-20 |
4 |
B |
$6.56 |
$58,923 |
D/D |
8,989 |
304,135 |
2.81 |
- |
|
| Quinn Anthony |
President & CEO |
• • – |
2019-05-17 |
4 |
B |
$6.65 |
$41,335 |
D/D |
6,218 |
295,146 |
2.81 |
- |
|
| Quinn Anthony |
President & CEO |
• • – |
2019-05-16 |
4 |
B |
$6.83 |
$37,691 |
D/D |
5,520 |
288,928 |
2.81 |
- |
|
| Quinn Anthony |
President & CEO |
• • – |
2019-05-15 |
4 |
B |
$6.76 |
$42,269 |
D/D |
6,256 |
283,408 |
2.81 |
- |
|
| Quinn Anthony |
President & CEO |
• • – |
2019-02-15 |
4 |
B |
$7.10 |
$5,103 |
D/D |
719 |
277,152 |
2.81 |
- |
|
| Quinn Anthony |
President & CEO |
• • – |
2019-02-06 |
4 |
OE |
$5.46 |
$54,126 |
D/D |
8,756 |
276,433 |
|
- |
|
| Quinn Anthony |
President & CEO |
• • – |
2018-12-07 |
4 |
OE |
$4.11 |
$751,816 |
D/D |
171,890 |
267,677 |
|
- |
|
| Schuchart Aaron |
Chief Business Officer |
• – – |
2018-09-27 |
4 |
S |
$9.50 |
$57,005 |
D/D |
(6,000) |
2,500 |
|
- |
|
| Schuchart Aaron |
Chief Business Officer |
• – – |
2018-08-17 |
4 |
OE |
$3.50 |
$29,750 |
D/D |
8,500 |
8,500 |
|
- |
|
| Quinn Anthony |
President & CEO |
• • – |
2018-08-15 |
4 |
B |
$9.13 |
$9,075 |
D/D |
994 |
95,787 |
2.81 |
- |
|
| Georgiou George |
Director |
– • – |
2018-08-13 |
4 |
OE |
$4.73 |
$220,784 |
D/D |
37,333 |
175,861 |
|
- |
|
| Quinn Anthony |
Interim CEO |
• • – |
2018-07-12 |
4 |
OE |
$6.31 |
$262,764 |
D/D |
38,866 |
92,793 |
|
- |
|
| Quinn Anthony |
Interim CEO |
• • – |
2018-07-11 |
4 |
OE |
$5.46 |
$18,056 |
D/D |
3,307 |
53,927 |
|
- |
|
| Novartis Ag |
|
• • • |
2018-05-11 |
4 |
S |
$10.06 |
$196,673 |
D/D |
(19,550) |
2,175,314 |
|
- |
|
92 Records found
|
|
Page 2 of 4 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
